ALMASS bench for MALDI-TOF MS

Related products

• 

  ALMASS

  «ALMASS Bio» Reagent kit

  For preparation of microorganism samples and calibration of masses for MALDI-TOF spectrometry.

  It is intended for preparation of samples of microorganisms of 3-4 pathogenicity groups for species identification and calibration of MALDI-TOF mass spectrometers by typical Escherichia coli protein profile. The principle of the method is based on treatment of analyzed samples with a matrix to reduce the destructive properties of laser radiation and also obtaining mass spectra of protein profiles of identified microorganisms.

  • Adapted for the ALMASS Bio» System (Algimed Techno LLC, Russia) or similar MALDI-TOF mass spectrometers.
  • Different versions of the kit depending on the user’s needs.
  • Designed for up to 9,000 identifications*.
• 

  ALMASS

  «ALMASS Bio» MALDI TOF MS System

  Identification of microorganisms.

  Designed for fast and reliable identification of microorganisms by mass spectrometry using a unique protein spectrum for each species – «molecular fingerprint».

  • Two versions: «ALMASS Bio 60» & «ALMASS Bio 200».
  • Best resolution in its class.
  • Own local database of microorganisms (more than 2700 species & 7600 strains) with the possibility of independent supplementation by the user.
  • Productivity of over 2,000 identifications per workday.
  • Comprehensive workplace equipment: special furniture and reagent kits can be supplied.
• 

  ALMASS

  «ALMASS Bench» for HPLC-MS

  For installation of HPLC-MS systems.

  Designed for installation of HPLC-MS systems.

  • Benchtop, cm (W x H x D) – 190 x 85 x 88;
  • Space for forevacuum pumps, mm (H x D x W) – 615 x 545 x 861;
  • Space for gas generator, mm (H x D x W) – 841 x 798 x 861;
  • Weight, kg – no more than 200 kg.
• 

  ALMASS

  «ALMASS Neo» Reagent kits

  For the detection of newborn metabolic disorders by HPLC-MS/MS.

  Designed for early screening of newborn’s metabolic disorders by quantitative determination of common amino acids, acylcarnitines, nucleosides, succinylacetone and lysophospholipids in peripheral blood samples.

  • Test for up to 57 analytes including 14 amino acids, 36 acylcarnitines, 2 nucleosides, succinylacetone and 4 lysophospholipids.
  • Ability to screen more than 30 forms of metabolic disorders of newborns.
  • The efficient and cost-effective way to expand newborn screening.
  • Suitable for mass screening.
• 

  ALMASS

  «ALMASS Neo» Assay solutions

  For the detection of newborn metabolic disorders by HPLC-MS/MS.

  Designed to extract target analytes from newborn’s peripheral blood samples on standard paper test blanks and transfer them to a tandem mass spectrometry system.

  • They are intended to use with the «ALMASS Neo» Reagent kits for early screening of newborn’s metabolic disorders.